The Water Street Collective secures £10.7m for well-being product development

The development of well-being and stimulation products is the core focus of The Water Street Collective Limited, which has just secured an estimated £10.7m in new funding. Based in London, the company operates as a wholly owned subsidiary of British American Tobacco (BAT) and produces innovative consumer goods, including its Ryde range of functional shots.

Incorporated in 2022, the business aims to provide solutions for individuals managing the demands of everyday life. While it is a subsidiary of BAT, the collective operates as an independent entity. It maintains a partnership with BTomorrow Ventures to facilitate access to scientific research and R&D resources for its product line.

Financial accounts for the year ended 31 December 2024 show the company generated £2m in revenue. During the same period, it recorded a £23.4m loss. The company reported 45 employees in its latest financial filings, while LinkedIn data indicates a current headcount of 29 staff members.

This estimated £10.7m round (allotted in April and filed in May) follows several previous capital injections. The company raised £16.2m in February and £5.3m in October 2025. During 2024, the firm secured three separate rounds of £9.5m, £5m, and £5.1m. Funding in 2023 consisted of a £16.7m round in November and a £14.6m round in January.

The Water Street Collective uses its capital to bring its well-being products to market, specifically targeting the food and beverage services industry. Its primary product line, Ryde, consists of functional shots marketed for their stimulation and well-being properties. The company continues to operate from its headquarters in London.